INHIBITION OF ALLERGIC AND NONALLERGIC LEUKOTRIENE-C4 FORMATION AND HISTAMINE-SECRETION BY AZELASTINE - IMPLICATION FOR ITS MECHANISM OF ACTION

被引：40

作者：

CHAND, N

PILLAR, J

NOLAN, K

DIAMANTIS, W

SOFIA, RD

机构：

来源：

INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY | 1989年 / 90卷 / 01期

关键词：

D O I：

10.1159/000235002

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：67 / 70

页数：4

共 25 条

[21]

SOFIA RD, 1988, J ALERGY CLIN IMMUNO, V81, P277

[22] PHARMACODYNAMIC EVALUATION OF AZELASTINE IN SUBJECTS WITH ASTHMA [J].

SPECTOR, SL ;

PERHACH, JL ;

ROHR, AS ;

RACHELEFSKY, GS ;

KATZ, RM ;

SIEGEL, SC .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 80 (01) :75-80

[23]

TANIGAWA T, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1212

[24] STUDIES ON METABOLIC-FATE OF A NEW ANTI-ALLERGIC AGENT, AZELASTINE (4-(PARA-CHLOROBENZYL)-2-[N-METHYLPERHYDROAZEPHINYL-(4)]-1-(2H)-PHTHALAZINONE HYDROCHLORIDE) [J].

TATSUMI, K ;

OU, T ;

YAMADA, H ;

YOSHIMURA, H .

JAPANESE JOURNAL OF PHARMACOLOGY, 1980, 30 (01) :37-48

[25] EVALUATION OF THE SAFETY AND EFFICACY OF LONG-TERM USE OF MULTIPLE DOSES OF AZELASTINE (AZ) IN ASTHMATICS [J].

TINKELMAN, D ;

BUCHOLTZ, G ;

KEMP, J ;

REPSHER, L ;

SPECTOR, S ;

STORMS, W ;

VANAS, A ;

KOEPKE, J .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) :280-280

← 1 2 3 →